David Hung, Director at NovoCure, holds 32.08K shares in NovoCure (Ticker: NVCR), holds ― shares in Establishment Labs Holdings (Ticker: ESTA), holds ― shares in ARYA Sciences Acquisition (Ticker: ~ARYA).
David Hung latest transaction was an Uninformative Buy of ―.
What was David Hung's most profitable transaction?
David Hung’s most profitable transaction was an Informative Buy of NUVB stock on June 18, 2025. The return on the trade was 210.60%.
What is David Hung's role in NovoCure?
David Hung's role in NovoCure is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.